Evidências científicas sobre a presença de transtornos mentais resultantes da infecção por SARS-CoV-2 em pessoas com COVID-19: scoping review
DOI:
https://doi.org/10.33448/rsd-v11i8.26562Palavras-chave:
SARS-CoV-2; COVID-19; Transtornos mentais; Psicopatologia.Resumo
Objetivos: Identificar evidências científicas sobre a presença de transtornos mentais em decorrência da infecção por SARS-CoV-2, em pessoas diagnosticadas com COVID-19; identificar os tipos de transtornos mentais; descrever a associação fisiopatológica da infecção por SARS-CoV-2 com os transtornos mentais; e descrever as características de idade e sexo da população estudada. Trata-se de uma Scoping Review realizada nas bases de dados: MEDLINE via PubMed, CINAHL, Web of Science, BVS, Cochrane Library, SCOPUS, Embase, LILACS. E nos seguintes sites: Google Scholar, ProQuest Dissertations and Theses e Grey Literature. Foram utilizados os descritores (comorbidity OR sequel OR complications) AND (Mental Health OR Mental disorders OR Mental Illness) AND (SARS-CoV-2 OR COVID-19 OR coronavirus). Os critérios de inclusão foram: artigos que respondessem à questão norteadora, disponíveis na íntegra, com abordagens metodológicas variadas, online, em inglês, espanhol e português. Excluíram-se: artigos sem livre acesso; cartas ao editor de cunho opinativo; editoriais; e livros. Selecionaram-se 10 estudos, que apontaram a alta prevalência de ocorrência de transtornos mentais em pacientes diagnosticados com COVID-19, sua etiologia é multifatorial, sendo atribuída aos danos do processo infeccioso e aos agentes estressores, resultantes da pandemia atual. Os transtornos encontrados foram: transtornos estressores; de humor; psicóticos; obsessivo-compulsivo; de ansiedade e sono-vigília. Os que tiveram maior prevalência de acometimento foram de ansiedade e depressão. Não houve diferença significativa com relação a prevalência por sexo. A média de idade dos participantes foi de 46,1 anos. Assim, faz-se necessário o conhecimento das possíveis sequelas da COVID-19, visando, oferecer suporte de forma integral a esta população.
Referências
Almutairi, M. et al (2021). Neuroinflammation and Its Impact on the Pathogenesis of COVID-19. Front Med (Lausanne), 8: 745789. https://doi.org/10.3389/fmed.2021.745789
APA. American Psychiatric Association (2014). Manual diagnóstico e estatístico de transtornos mentais: DSM-5.
Banerjee, D. (2020). The impact of Covid-19 pandemic on elderly mental health. Inter. Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.5320.
Bastien, C. et al (2001). Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med., 2: 297– 307. https://doi.org/10.1016/S1389-9457(00)00065-4.
Bo, H-X. et al (2021). Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China. Psychological Medicine, vol 5. https://doi.org/10.1017/S0033291720000999.
Bottemanne, H., et al (2021). SARS-CoV-2 Psychiatric Sequelae: An Urgent Need of Prevention. Front Psychiatry, 9,12:738696. https://doi.org/10.3389/fpsyt.2021.738696.
Brooks, S., et al (2020). The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet, 395:912–20. 2020. https://doi.org/10.1016/S0140-6736(20)30460-8.
Casagrande, M., et al (2020). The enemy who sealed the world: effects quarantine due to the COVID-19 on sleep quality, anxiety, and psychological distress in the Italian population. Sleep Med., 75:12-20. https://doi.org/10.1016/j.sleep.2020.05.011.
Cai, X., et al (2020). Psychological Distress and Its Correlates Among COVID-19 Survivors During Early Convalescence Across Age Groups. Am J Geriatr Psychiatry,28(10):1030-1039. https://doi.org/10.1016/j.jagp.2020.07.003.
Cevik, M., et al (2020). Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. https://doi.org/10.1136/bmj.m3862
Centers for Disease Control and Prevention (2021a). About COVID-19. www.cdc.gov.
Centers for Disease Control and Prevention (2021b). Symptons. www.cdc.gov.
Chen, J., (2020). Pathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging viroses. Microbes and Infection, 22. https://doi.org/10.1016/j.micinf.2020.01.004.
Deng, J., et al (2021). The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci.,1486(1):90-111. 2021. https://doi.org/10.1111/nyas.14506.
Desai, S., et al (2021). New-Onset Psychosis Following COVID-19 Infection. Cureus, 13(9):e17904. 10.7759/cureus.17904
Ferrando, S., et al (2020). COVID-19 Psychosis: A Potential New Neuropsychiatric Condition Triggered by Novel Coronavirus Infection and the Inflammatory Response? Psychosomatics, 61(5):551-555. https://doi.org/10.1016/j.psym.2020.05.012Get.
Galvão, T. F., Pansani, T. S. A. & Harrad, D. (2015). Principais itens para relatar Revisões sistemáticas e Meta-análises: A recomendação PRISMA*. Epidemiol. Serv. Saúde, 24(2): abr-jun. https://doi.org/10.5123/S1679-49742015000200017.
Generoso, J., et al (2021). Neurobiology of COVID-19: how can the virus affect the brain? Braz J Psychiatry., 43(6): 650–664.https://doi.org/10.1590/1516-4446-2020-1488.
Guo, Q., et al (2020). Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: A mixed-method study. Brain Behav Immun, 88:17-27. https://doi.org/10.1016/j.bbi.2020.05.038.
Hu, Y., et al (2020). Factors related to mental health of inpatients with COVID-19 in Wuhan, China. Brain Behav Immun.,89:587-593. https://doi.org/10.1016/j.bbi.2020.07.016.
Janiri, D., et al (2021). Posttraumatic Stress Disorder in Patients After Severe COVID-19 Infection. JAMA Psychiatry, 78(5):567-569. 10.1001/jamapsychiatry.2021.0109
Jha, N, et al (2021). Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations. J Mol Neurosci.,71(11):2192-2209. 10.1007/s12031-020-01767-6
Kar, S., et al (2020). Mental illnesses among COVID-19 patients: Possible immunological underpinnings. Asian J Psychiatr., 53: 102376.10.1016/j.ajp.2020.102376.
Khademil, M., et al (2021). Prevalence of Mental Health Problems and Its Associated Factors Among Recovered COVID-19 Patients During the Pandemic: A Single-Center Study. Front. Psychiatry. https://doi.org/10.3389/fpsyt.2021.602244.
Khan, S., et al (2021). Mental health consequences of infections by coronaviruses including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Brain Behav., 11(2):e01901. https://doi.org/10.1002/brb3.1901.
Kong, X., et al (2020). Prevalence and Factors Associated with Depression and Anxiety of Hospitalized Patients with COVID-19. MedRxiv and bioRxiv. https://doi.org/10.1101/2020.03.24.20043075
Kong, X, et al (2020). Effect of Psychological–Behavioral Intervention on the Depression and Anxiety of COVID-19 Patients. Front. Psychiatry. https://doi.org/10.3389/fpsyt.2020.586355.
Kroenke, K., et al (2001). PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9). https://doi.org/10.1046/j.1525-1497.2001.016009606.x.
Lai, J., et al (2020). Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA Netw Open, 3(3):e203976. 10.1001/jamanetworkopen.2020.3976.
Lakhan, R., et al (2020). Prevalence of Depression, Anxiety, and Stress during COVID-19 Pandemic. J Neurosci Rural Pract., 11(4):519-525. 10.1055/s-0040-1716442
Lee, A, et al (2007). Stress and psychological distress among SARS survivors 1 year after the outbreak. Can J Psychiatry, 52(4):233-40. 10.1177/070674370705200405
Li, Y-C., et al (2020). The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol., 92(6):552-555. 10.1002/jmv.25728
Lima, A. A., et al. (2021). Characteristics of SARS-cov-2 aerosol dispersion in indoor air: scoping review. Research, Society and Development, 10(4), e44310414300. http://dx.doi.org/10.33448/rsd-v10i4.14300.)
Liu, X., et al (2021). Public mental health problems during COVID-19 pandemic: a large-scale meta-analysis of the evidence. Transl Psychiatry,384. https://doi.org/10.1038/s41398-021-01501-9.
Mascarello, K., et al (2021). Hospitalização e morte por COVID-19 e sua relação com determinantes sociais da saúde e morbidades no Espírito Santo: um estudo transversal. Epidemiol. Serv. Saude, 30(3):e2020919. 10.1590/S1679-49742021000300004.
Moreira, J. L., et al (2021). The psychiatric and neuropsychiatric repercussions associated with severe infections of COVID-19 and other coronaviruses. Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 106. https://doi.org/10.1016/j.pnpbp.2020.110159.
Morettin, P, & Singer, Julio (2021). Estatística e Ciência de Dados. Departamento de Estatística Universidade de São Paulo.
Morin, C., et al (2021). Insomnia, anxiety, and depression during the COVID-19 pandemic: an international collaborative study. Sleep Medicine, vol. 87. https://doi.org/10.1016/j.sleep.2021.07.035
Nakamura, Z., et al (2021). Neuropsychiatric Complications of COVID-19. Curr Psychiatry Rep.,16,23(5):25. 10.1007/s11920-021-01237-9
Napoleão, R. N., et al (2021). COVID-19: Compreendendo a “tempestade de citocinas”. Research, Society and Development, v. 10, n.5, e43710515150. 10.33448/rsd-v10i5.15150.
Organização Pan-Americana de Saúde (2020). Histórico da pandemia de COVID-19. https://www.paho.org/pt/covid19/historico-da-pandemia-covid-19.
Organização Pan-Americana de Saúde (2021). Coronavírus. https://www.paho.org/pt/topicos/coronavírus.
Ornell, F., et al (2020). “Pandemic fear” and COVID-19: mental health burden and strategies. Braz J Psychiatry. http://dx.doi.org/10.1590/1516-4446-2020-0008.
Pallanti, S., et al (2021). Neurocovid-19: A clinical neuroscience-based approach to reduce SARS-CoV-2 related mental health sequelae. J Psychiatr Res.,130:215-217. 10.1016/j.jpsychires.2020.08.008.
Parra, A. et al (2020). Psychotic symptoms in COVID-19 patients. A retrospective descriptive study. Psychiatry Res, 291:113254. 10.1016/j.psychres.2020.113254.
Peters, M. D. J. et al. (202). Chapter 11: Scoping Reviews (2020 version). JBI Manual for Evidence Synthesis.
Purssell, E., et al (2020). Impact of isolation on hospitalised patients who are infectious: systematic review with meta-analysis. BMJ Open, 18,10(2):e030371. 10.1136/bmjopen-2019-030371.
Qi, R., et al (2020). Psychological morbidities and fatigue in patients with confirmed COVID-19 during disease outbreak: prevalence and associated biopsychosocial risk factors. MedRxiv and bioRxiv. https://doi.org/10.1101/2020.05.08.20031666.
Raijkumar, R. (2020b). Contamination and infection: What the coronavirus pandemic could reveal about the evolutionary origins of obsessive-compulsive disorder. Psychiatry Research., 289. https://doi.org/10.1016/j.psychres.2020.113062.
Raijkumar, R. (2020a). COVID-19 and mental health: A review of the existing literature. Asian Journal of Psychiatry, 52. https://doi.org/10.1016/j.ajp.2020.102066.
Resende, M., et al (2015). O DSM-5 e suas implicações no processo de medicalização da existência. Psicol. rev., 21(3), 534-546. 2015. http://dx.doi.org/DOI-10.5752/P.1678-9523.2015v21n3p534.
Rogers, J., et al (2021). Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry, 7:611. https://doi.org/10.1016/S2215-0366(20)30203-0
Sadeghi, M., et al (2016). Validity and Reliability of Persian Version of “Post-Traumatic Stress Disorder Scale” in War Veterans. Iran J War Public Health, 8:243–9. https://ijwph.ir/article-1-596-en.html.
Shafran, R, et al (2020). Recognising and addressing the impact of COVID-19 on obsessive-compulsive disorder. Lancet Psychiatry, 7(7):570-572. 10.1016/S2215-0366(20)30222-4.
Shi, L. et al (2020). Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic. JAMA Netw Open., 3(7):e2014053. 10.1001/jamanetworkopen.2020.14053
Shin, L., & Liberzon, I. (2010). The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology, 35:169-91. https://www.nature.com/articles/npp200983
Spitzer, R., et al (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med., 166. 10.1001/archinte.166.10.1092.
Taquet, M. et al (2021). 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry, 8: 416–27. https://doi.org/10.1016/S2215-0366(21)00084-5.
Uher, R, & Zwicker, A. (2017). Etiology in psychiatry: embracing the reality of poly‐gene‐environmental causation of mental illness. World Psychiatry, 16(2):121-129. https://doi.org/10.1002/wps.20436
World Health Organization (2021a). Mental health & COVID-19. www.who.in. https://www.who.int/teams/mental-health-and-substance-use/mental-health-and-covid-19.
World Health Organization (2021b). WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int.
Wu, T., et al (2021). Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis. J Affect Disord, 281:91-98. https://doi.org/10.1016/j.jad.2020.11.117.
Xia, H. & Lazartigues, E. (2008). Angiotensin-converting enzyme 2 in the brain: properties and future directions. J Neurochem. 2008. 10.1111/j.1471-4159.2008. 05723.x.
Yadav, R. et al (2021). Assessment of Depression, Anxiety, and Sleep Disturbance in COVID-19 Patients at Tertiary Care Center of North India. J Neurosci Rural Pract., 12(2):316-322. 10.1055/s-0040-1722811.
Yachou, Y., et al (2020). Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci.,41(10):2657-2669. 10.1007/s10072-020-04575-3.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2022 Izabelly Carollynny Maciel Nunes; Verônica de Medeiros Alves; Anyele Albuquerque Lima; Alda Graciele Claudio dos Santos Almeida; Ana Paula Nogueira de Magalhães
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Autores que publicam nesta revista concordam com os seguintes termos:
1) Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Attribution que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
2) Autores têm autorização para assumir contratos adicionais separadamente, para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.
3) Autores têm permissão e são estimulados a publicar e distribuir seu trabalho online (ex.: em repositórios institucionais ou na sua página pessoal) a qualquer ponto antes ou durante o processo editorial, já que isso pode gerar alterações produtivas, bem como aumentar o impacto e a citação do trabalho publicado.
